يعرض 1 - 20 نتائج من 1,192 نتيجة بحث عن '"Kalso, Eija A. A."', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: HUS Perioperative, Intensive Care and Pain Medicine, Eija Kalso / Principal Investigator, Clinicum, Anestesiologian yksikkö, University of Helsinki, SLEEPWELL Research Program, Faculty of Medicine

    مصطلحات موضوعية: Surgery, anesthesiology, intensive care, radiology

    وصف الملف: application/pdf

    Relation: G. Pickering has received consultancy fees from Gr\u00FCnenthal, Mylan, Sanofi and Haleon. M. O'Keeffe is supported by an Irish fellowship (UCD Ad Astra Fellowship) and has received funding from the European Union. K. Bannister is part funded by the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. E. Eisenberg has received research grants, consulting or speaking fees and/or honoraria from the Israel Pain Association, Rafa Laboratories, Syqe Medical, Teva Israel, Pfizer, Little Green Pharma, Bioevents, Greenwich Biosciences, Vectura Ferin Pharma and Cannabotech. D.P Finn has received research grants in cannabinoids or the endocannabinoid system and pain from Shionogi Ltd. (Shionogi Science Programme) and from B. Braun Ltd. jointly with Science Foundation Ireland. P. Forget has received speaker/advisory board fees from Grunenthal, Oncomfort and GE Healthcare. T. Graven\u2010Nielsen is supported by the Danish National Research Foundation (DNRF121). E. Kalso has participated in advisory boards of Orion Pharma (Espoo, Finland) and Pfizer (New York, New York) and has received lecture fees from Orion Pharma, GSK (Brentford, United Kingdom) and Merck (Rahway, New Jersey). T. R. T\u00F6lle declares consultancies, travel grants and speaking fees for AOP Orphan, Almiral Hermal, Bionest Partners, Benkitt Renkiser, Gr\u00FCnenthal, Hexal, Indivior, Kaia Health, Lilly, Medscape Mundipharma, MSD, Novartis, Pfizer, Recordati Pharma, Sanofi\u2010Aventis and TAD Pharma. A. Truini has received consulting fees or payment for lectures from Angelini, Grunenthal, Viatris and Eliem Therapeutics. E. Pogatski Zahn has received financial support from Grunenthal for research activities and advisory and lecture fees from Gr\u00FCnenthal, Novartis, Medtronic and Merck/MSD. In addition, her current research is supported by the German Research Foundation (DFG), the Federal Ministry of Education and Research (BMBF), the Federal Joint Committee (G\u2010BA) and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777500. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. L. Garcia\u2010Larrea is supported by the French National Institute for Health and Medical Research (INSERM) and has no COI to declare. BM. Fullen has received funding from the European Union, advisory fees from Grunenthal and an unrestricted grant from Asaki Kasei. The other authors have no financial interests to declare. In July 2023, the EFIC SWG received funding from ERA\u2010NET NEURON (The Networking of European Funding for Neuroscience Research) to establish a European networking group about the future of pain research (Pain Research Strategy for Europe: PRiSE). This initiative was aimed at advancing the development and implementation of the EFIC Research Strategy. The ERA\u2010NET Working Group (ERA\u2010NET WG) included all 14 members of the EFIC\u2010SWG and expanded to include 12 new members who brought additional perspectives and clinical and research expertise from European countries not initially represented. With a total of 26 individuals from 23 European countries, the ERA\u2010NET WG met for face\u2010to\u2010face and online meetings over a 12\u2010month period. This project received funding from the Network of European Funding for Neuroscience Research (ERA\u2010NET Neuron Transnational Networking Groups on Chronic Pain 2022.ANR\u201023\u2010NEUG\u20100001\u201001).; http://hdl.handle.net/10138/589121; 85211445229; 001373150000001

  8. 8
    Academic Journal

    المساهمون: HUS Perioperative, Intensive Care and Pain Medicine, Anestesiologian yksikkö, Clinicum, University of Helsinki, SLEEPWELL Research Program, HUS Children and Adolescents, Children's Hospital, Eija Kalso / Principal Investigator, Department of Pharmacology, Medicum, Department of General Practice and Primary Health Care

    مصطلحات موضوعية: Neurology and psychiatry

    وصف الملف: application/pdf

    Relation: The work has been supported by the European Union Seventh Framework Programmes, NeuroPain under grant agreement no. 602891 (to E.K. and A.S.C.R.), ncRNAPain under grant agreement no. 602133 (to F.B.), and the Berufsgenossenschaft fur das Gesundheitswesen Mainz (to F.B.). The funders had no role in method design, data selection and analysis, decision to publish, or preparation of the manuscript.; Bibtex: SipiläKalsoKempZettermanLozanoRiceBirkleinDimova+2024; http://hdl.handle.net/10138/588335; 001349787800001

  9. 9
    Academic Journal

    المساهمون: Hôpital Raymond Poincaré AP-HP, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université Paris-Saclay, Physiopathologie et Pharmacologie Clinique de la Douleur (LPPD), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Jena University Hospital Jena, Cliniques universitaires St Luc Bruxelles, Université Catholique de Louvain = Catholic University of Louvain (UCL), Hôpital Ambroise Paré AP-HP, Helsinki University Hospital Finland (HUS), Helsingin yliopisto = Helsingfors universitet = University of Helsinki, University Hospital Münster - Universitaetsklinikum Muenster Germany (UKM), Friedrich-Schiller-Universität = Friedrich Schiller University Jena Jena, Germany, European Federation of Pharmaceutical Industries and Associations, IMI-PainCare consortium, European Union s Horizon2020 research and innovation program, Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, IMI-PainCare, European Commission, Innovative Medicines Initiative

    المصدر: ISSN: 0265-0215.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    Relation: info:eu-repo/semantics/altIdentifier/pmid/38414426; PUBMED: 38414426; PUBMEDCENTRAL: PMC10990022

  10. 10
    Academic Journal

    المساهمون: HUS Perioperative, Intensive Care and Pain Medicine, Institute for Molecular Medicine Finland, Eija Kalso / Principal Investigator, Clinicum, Research Programs Unit, Anestesiologian yksikkö, SLEEPWELL Research Program

    وصف الملف: application/pdf

    Relation: The facilities and expertise of FIMM Metabolomics, supported by HiLIFE and Biocenter Finland, are gratefully acknowledged. We thank Les Hearn, MSc, for proofreading the manuscript for English.; Zetterman , T , Nieminen , A I , Markkula , R , Kalso , E & Lötsch , J 2024 , ' Machine learning identifies fatigue as a key symptom of fibromyalgia reflected in tyrosine, purine, pyrimidine, and glutaminergic metabolism ' , Clinical and translational science , vol. 17 , no. 3 , e13740 . https://doi.org/10.1111/cts.13740; ORCID: /0000-0001-8999-6040/work/156647442; ORCID: /0000-0001-8314-1439/work/156652927; http://hdl.handle.net/10138/573649; 41c2999d-9a5b-4ce2-911a-50deaea4896b; 001173521200001

  11. 11
    Academic Journal

    المساهمون: HUS Medical Imaging Center, HUS Diagnostic Center, HUS Neurocenter, Kliinisen neurofysiologian yksikkö, Department of Neurosciences, BioMag Laboratory, HUS Perioperative, Intensive Care and Pain Medicine, Eija Kalso / Principal Investigator, Clinicum, SLEEPWELL Research Program, Anestesiologian yksikkö, Neurologian yksikkö

    مصطلحات موضوعية: Crps, rTMS, Secondary somatosensory cortex, Sleep, Neurosciences

    وصف الملف: application/pdf

    Relation: Biomedicum Helsinki Foundation, Grant/Award Number: 20220071; Signe and Ane Gyllenberg Foundation, Grant/Award Number: 5672; Maud Kuistila Memorial Foundation, Grant/Award Number: 2022-0031B; The state funding for university-level health research, Grant/Award Number: TYH2016222;TYH2021-215; Vanhanen , J , Kujala , J , Liljeström , M , Kalso , E , Virkkala , J & Harno , H 2023 , ' rTMS targeted to the secondary somatosensory cortex influences sleep in CRPS patients, as measured with the OURA ring ' , Brain and Behavior , vol. 13 , no. 11 , e3252 . https://doi.org/10.1002/brb3.3252; http://hdl.handle.net/10138/572429; 899c18d2-3ea5-4979-b462-faf29aeeafb2; 001075638400001

  12. 12
    Academic Journal

    المساهمون: HUS Perioperative, Intensive Care and Pain Medicine, Eija Kalso / Principal Investigator, Clinicum, Anestesiologian yksikkö

    وصف الملف: application/pdf

    Relation: This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777500. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA Companies. JV received payments for advisory boards and talks outside of the submitted work from Embody Orthopaedics, UK, and Casquar, Germany. EK has received fees for advisory board or lecture activities from Oriona Pharma, Finland, Pfizer, Sweden, and GSK, Finland. WM received payments for advisory boards and talks outside of the submitted work from Kyowa Japan, Mundipharma Singapore, Grünenthal, Germany Ethypharm, France, and Spectrum Therapeutics, Germany. His institution received research support from Pfizer, USA, Mundipharma, Germany, and Grünenthal, Germany. EMPZ received financial support from Grünenthal, Germany, for research activities and advisory and lecture fees from Grünenthal, Germany, Novartis, Germany, and Medtronic, Switzerland. In addition, she receives scientific support from the German Research Foundation (DFG), the Federal Ministry of Education and Research (BMBF), the Federal Joint Committee (G-BA), and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777500. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. All money went to the institutions (WWU/UKM) EMPZ is working for. All the other authors have no conflicts of interest to declare.; Vollert , J , Segelcke , D , Weinmann , C , Schnabel , K , Fuchtmann , F , Rosenberger , D C , Komann , M , Maessen , T , Sauer , L , Kalso , E , Fletcher , D , Lavand'homme , P , Kaiser , U , Liedgens , H , Meissner , W & Pogatzki-Zahn , E M 2024 , ' Responsiveness of multiple patient-reported outcome measures for acute postsurgical pain : primary results from the international multi-centre PROMPT NIT-1 study ' , British Journal of Anaesthesia , vol. 132 , no. 1 , pp. 96-106 . https://doi.org/10.1016/j.bja.2023.10.020; http://hdl.handle.net/10138/570650; e7b04918-90ae-46ea-8934-a68267c65b1c; 85180240630; 001165398200001

  13. 13
    Academic Journal

    المساهمون: Department of Diagnostics and Therapeutics, HUS Perioperative, Intensive Care and Pain Medicine, Anestesiologian yksikkö, University of Helsinki, Department of Public Health, HUS Helsinki and Uusimaa Hospital District, Clinicum, INDIVIDRUG - Individualized Drug Therapy, Faculty of Medicine, Institute for Molecular Medicine Finland, Helsinki Institute of Life Science HiLIFE, Eija Kalso / Principal Investigator, Department of Pharmacology, SLEEPWELL Research Program

    مصطلحات موضوعية: Surgery, anesthesiology, intensive care, radiology

    وصف الملف: application/pdf

    Relation: Supported by Academy of Finland (Helsinki, Finland) grant Nos. 110489 and 217028; Governmental Research Funds for University Level Health Research (Helsinki, Finland) grant Nos. TYH2008225 and TYH2010210 (to Dr. Kalso); and a stipend from The Finnish Society of Anesthesiologists (Finland), Helsinki University Hospital Research Funds and Finnish Medical Foundation grant No. 4840 (to Dr. Ahlstr\u00F6m). The authors thank Leslie Hearn, M.Sc. (London, United Kingdom), for proofreading the article and Eija R. Ruoppa, R.N., and Minna Kaiponen, R.N. (Department of Anesthesiology, Intensive Care and Pain Medicine, Helsinki University Hospital, Helsinki, Finland), for assistance throughout the project. The article processing charge was funded by the University of Helsinki. Supported by Academy of Finland (Helsinki, Finland) grant Nos. 110489 and 217028; Governmental Research Funds for University Level Health Research (Helsinki, Finland) grant Nos. TYH2008225 and TYH2010210 (to Dr. Kalso); and a stipend from The Finnish Society of Anesthesiologists (Finland), Helsinki University Hospital Research Funds and Finnish Medical Foundation grant No. 4840 (to Dr. Ahlstr\u00F6m).; Ahlström , S , Reiterä , P , Jokela , R , Olkkola , K T , Kaunisto , M A & Kalso , E 2024 , ' Influence of Clinical and Genetic Factors on Propofol Dose Requirements : A Genome-wide Association Study ' , Anesthesiology , vol. 141 , no. 2 , pp. 300-312 . https://doi.org/10.1097/ALN.0000000000005036; ORCID: /0000-0002-6946-9195/work/165729401; ORCID: /0000-0001-7872-8665/work/165730267; ORCID: /0000-0003-4672-2554/work/165731496; http://hdl.handle.net/10138/584597; 80de03f8-06d7-48d5-88b3-660f82c3f184; 85198672118; 001271418700028

  14. 14
    Academic Journal

    المساهمون: Neuroscience Center, INDIVIDRUG - Individualized Drug Therapy, Helsinki Institute of Life Science HiLIFE, SLEEPWELL Research Program, Division of Pharmacology and Pharmacotherapy, Department of Pharmacology, Divisions of Faculty of Pharmacy, HUSLAB, Medicum, Department of Physiology, HUS Perioperative, Intensive Care and Pain Medicine, Anestesiologian yksikkö, Tarja Stenberg / Principal Investigator, Eija Kalso / Principal Investigator, Clinicum

    وصف الملف: application/pdf

    Relation: http://hdl.handle.net/10138/584381; 85199362186; 001272313900005

  15. 15
    Academic Journal

    المساهمون: Department of Pharmacology, Faculty of Medicine, Medicum, Institute for Molecular Medicine Finland, Research Programs Unit, Division of Pharmacology and Pharmacotherapy, Divisions of Faculty of Pharmacy, HUSLAB, HUS Perioperative, Intensive Care and Pain Medicine, Eija Kalso / Principal Investigator, Clinicum

    وصف الملف: application/pdf

    Relation: http://hdl.handle.net/10138/578828; 85195321708; 001252371400001

  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal

    المساهمون: Doctoral Programme in Drug Research, INDIVIDRUG - Individualized Drug Therapy, HUSLAB, Department of Clinical Pharmacology, Research Programs Unit, HUS Perioperative, Intensive Care and Pain Medicine, Janne Backman / Principal Investigator, Clinicum, HUS Emergency Medicine and Services, Eija Kalso / Principal Investigator, Anestesiologian yksikkö

    وصف الملف: application/pdf

    Relation: http://hdl.handle.net/10138/565510; 85161489597; 001002660400001